Ryan Arthur F
Director
1 company
Insider Signal Score
54
AverageTrades Analyzed
37
12M Win Rate
37.8%
Avg 3M Return
-2.8%
Avg 12M Return
-2.1%
Ryan Arthur F is a Director at REGENERON PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 123 sells.
Estimated insider holdings value: $13.4M based on current market prices.
Holdings by Company
REGNMay 1, 2026
Current Shares17.5K
Value$13.37M
Net Activity-13,974
Bought: 0Sold: 14.0K
Transaction History
Showing 10 filings (page 3)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2023 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $756.13 | $75,613.49 | - | +5.3% | +26.4% | |
| Jan 3, 2023 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 86 | $729.42 | $62,730.34 | - | +14.7% | +27.4% | |
| Dec 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $758.17 | $75,817.49 | - | +1.2% | +7.0% | |
| Nov 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $755.89 | $75,588.55 | - | -3.1% | +4.1% | |
| Oct 3, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $726.54 | $72,654.30 | - | -2.0% | +10.0% | |
| Sep 6, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $582.37 | $58,236.73 | - | +31.6% | +42.6% | |
| Aug 4, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 10,453 | $621.29 | $6,494,318.79 | -15.6% | +20.4% | +24.6% | |
| May 2, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $650.78 | $65,078.46 | - | -11.6% | +22.5% | |
| Apr 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $692.81 | $69,281.16 | - | -14.9% | +18.3% | |
| Mar 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $618.37 | $61,836.73 | - | +9.5% | +26.9% |